Probioksin No. 30 caps. PHARMACOTHERAPEUTIC GROUP: Simbiotik. Drug for restoration of intestinal microflora PHARMAKOLOGICHEKY PROPERTIES: Simbiotik for maintenance of healthy microflora. Probioksin has the normalizing effect on intestinal microflora: (microbiocenosis) supports and regulates physiological balance of intestinal microflora and provides its physiological functions in intestines. The therapeutic effect of Probioksin is defined by live lactobacilli and bifidobacteria which act as antagonists in relation to a wide range of pathogenic and opportunistic microorganisms. The lactobacilli which are Probioksin's part produce milk and, to a lesser extent, acetic and propylene acid. The acidic environment created in intestines is adverse for development of pathogenic and opportunistic microorganisms the Lactobacilli participate in a resorption of monosaccharides, metabolism of bile acids, stabilize cell membranes of an intestinal epithelium and regulate absorption of electrolytes and synthesis of vitamins (B1, B2, B6, B12, K, E, PP vitamins, ascorbic acid, biotin), create favorable conditions for absorption of iron, calcium, vitamin D. Probioksin's use facilitates proteopepsis, the fosfoproteinfosfataza of bifidobacteria participates in milk casein metabolism the Activity of intestinal microflora can be broken owing to a number of factors: intake of some medicines (antibiotics, laxative), unbalanced food with a large number prepared in the industrial way and the high-calorie products containing few ballast substances, a stress and tension, smoking and an alcohol abuse, by intoxication the substances arriving from the environment. Disturbance of harmonious balance of structure of intestinal microflora INDICATIONS can turn out to be consequence of all this: Disbioz of intestines (intestinal dysbiosis), including owing to reception of antibiotics, sulfanamide drugs and other chemotherapeutic means Chronic colitis of various etiology, including nonspecific ulcer colitis and Crohn's disease the Postponed acute intestinal infections the Chronic coloenteritis the Syndrome of the angry intestines Diarrhea of travelers, acute diarrhea Constipations, a meteorism Mycoses of an oral cavity and intestines Atopic diseases (atopic dermatitis / neurodermatitis, allergic rinokonjyunktivit) the Allergy (including an allergy to foodstuff), allergoses Chronic inflammatory diseases of skin (eels, a furunculosis) the DOSING MODE: At independent use by the consumer, it is recommended to respect the rules specified on packing. If drug is appointed by the doctor, changes in a dosage by the Adult are possible — on 1 capsule 3 times a day at meal time. To children from 6 years is also more senior — on 1 capsule 2 times a day at meal time. Duration of reception is 1-4 weeks of the CONTRAINDICATION: Hypersensitivity to Probioksin's components SIDE EFFECT: Reactions of individual intolerance USE AT PREGNANCY AND FEEDING by the BREAST are possible: As dietary supplements to food have free use by consumers, Probioksin is not recommended to be applied to pregnant women without medical prescription. The doctor, having defined requirement at the pregnant woman for similar drug, the PACKAGING appoints Probioksin: the N30 Capsules in high-quality, hermetically closed bank with a leaf insert in cardboard packing the EXPIRATION DATE: Specified on packing. Not to apply STORAGE CONDITIONS after expiry date: At a temperature not over 200C, in protected from light and out of children's reach PRESCRIPTION STATUS: Without prescription the Owner of a product and trademark is the company NOVATOR PHARMA LLP, London, Great Britain. Office 21, 8 Shepherd Market, London, W1J 7JY, UK Is manufactured in England by the company PRIMEA LIMITED, London, Great Britain